Medtronic announced the FDA approval of its Percept™ RC rechargeable Deep Brain Stimulation (DBS) system. Ths sensing-enabled IPG allows the physician to personalize treatment for patients with movement disorders such as Parkinson’s disease, essential tremor, and dystonia, as well as epilepsy.
According to the press release:
“Percept™ RC is the smallest and thinnest dual channel neurostimulator available for DBS. It is equipped with BrainSense™ technology that captures and records brain signals to provide insights that enable a healthcare provider to adapt and personalize therapy to a patient’s evolving needs. Unlike other rechargeable devices, the Percept™ RC battery offers at least 15 years of service life with consistent and fast recharge performance. Medtronic patented battery technology has less battery fade than other rechargeable devices for a more reliable, long-lasting battery. Patients can experience rapid recharging from 10% to 90% full charge in less than an hour.”